Antibody specificity identified at the Dept. of Immunotechnology is heading towards clinical trials
– Published 7 November 2024
Antibody AKIR001, the precursor of which was isolated at the SciLifeLab unit of the Dept. of Immunotechnology, in collaboration with Prof. Marika Nestor of Uppsala University, and other units of the SciLifeLab Drug Discovery and Development platform is heading for first-in-human clinical trials. For more information read additional information from Akiram Therapeutics and from ClinicalTrials.gov.